Media headlines about Omega Healthcare Investors (NYSE:OHI) have trended somewhat positive on Monday, according to Accern. The research firm ranks the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Omega Healthcare Investors earned a media sentiment score of 0.18 on Accern’s scale. Accern also assigned news headlines about the real estate investment trust an impact score of 45.8435487692936 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the media stories that may have impacted Accern Sentiment’s rankings:
- DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Omega Healthcare, Inc. Investors of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2018 – OHI (finance.yahoo.com)
- Rosen Law Firm Reminds Omega Healthcare, Investors Inc. Investors of Important January 16 Deadline in Class Action – OHI (finance.yahoo.com)
- Glancy Prongay & Murray LLP Reminds Investors of the January 16, 2018 Deadline in the Class Action Lawsuit Against Omega Healthcare Investors, Inc. (OHI) (finance.yahoo.com)
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Omega Healthcare, Inc. Investors of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2018 – OHI (finance.yahoo.com)
- DEADLINE ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Omega Healthcare Investors, Inc. (OHI) and Lead Plaintiff Deadline – January 16, 2018 (finance.yahoo.com)
OHI has been the topic of several recent analyst reports. Zacks Investment Research downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research report on Friday, November 3rd. Hilliard Lyons downgraded Omega Healthcare Investors to a “buy” rating in a research report on Wednesday, November 1st. Vetr cut Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $32.96 price objective on the stock. in a research report on Monday, October 30th. Stifel Nicolaus cut Omega Healthcare Investors from a “buy” rating to a “hold” rating and lowered their price objective for the company from $35.00 to $29.00 in a research report on Tuesday, October 31st. Finally, TheStreet cut Omega Healthcare Investors from a “b-” rating to a “c” rating in a research report on Monday, October 30th. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $32.14.
Omega Healthcare Investors (NYSE OHI) traded down $0.48 during trading on Monday, reaching $26.12. The company’s stock had a trading volume of 3,285,400 shares, compared to its average volume of 2,280,000. The company has a current ratio of 3.40, a quick ratio of 3.40 and a debt-to-equity ratio of 1.18. The firm has a market capitalization of $5,150.00, a price-to-earnings ratio of 34.37, a P/E/G ratio of 2.70 and a beta of 0.49. Omega Healthcare Investors has a one year low of $26.06 and a one year high of $35.14.
Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Monday, October 30th. The real estate investment trust reported ($0.67) EPS for the quarter, missing analysts’ consensus estimates of $0.83 by ($1.50). Omega Healthcare Investors had a return on equity of 3.92% and a net margin of 17.61%. equities analysts forecast that Omega Healthcare Investors will post 3.21 EPS for the current year.
In other news, Director Craig R. Callen purchased 10,000 shares of the business’s stock in a transaction dated Thursday, November 2nd. The shares were acquired at an average price of $27.38 per share, with a total value of $273,800.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bernard J. Korman purchased 100,000 shares of the business’s stock in a transaction dated Tuesday, October 31st. The shares were purchased at an average cost of $28.24 per share, for a total transaction of $2,824,000.00. Following the purchase, the director now directly owns 903,895 shares of the company’s stock, valued at $25,525,994.80. The disclosure for this purchase can be found here. In the last three months, insiders acquired 210,000 shares of company stock worth $5,786,800. Insiders own 1.54% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This story was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another site, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/15/omega-healthcare-investors-ohi-getting-somewhat-favorable-press-coverage-analysis-shows.html.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.